Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Mar 23, 2026
Sale
Shares
640
Price
$526.59
Total Value
$337.01K
Shares Held After
44,833
% of Holdings
1.4%
Mar 23, 2026
Sale
Shares
400
Price
$525.43
Total Value
$210.17K
Shares Held After
45,473
% of Holdings
0.9%
Mar 23, 2026
Sale
Shares
647
Price
$524.15
Total Value
$339.12K
Shares Held After
45,873
% of Holdings
1.4%
Mar 23, 2026
Sale
Shares
160
Price
$522.19
Total Value
$83.55K
Shares Held After
46,520
% of Holdings
0.3%
Mar 23, 2026
Sale
Shares
1,320
Price
$521.38
Total Value
$688.22K
Shares Held After
46,680
% of Holdings
2.8%
Mar 23, 2026
Sale
Shares
867
Price
$520.54
Total Value
$451.31K
Shares Held After
48,000
% of Holdings
1.8%
Mar 23, 2026
Sale
Shares
906
Price
$519.29
Total Value
$470.48K
Shares Held After
48,867
% of Holdings
1.8%
Mar 23, 2026
Sale
Shares
240
Price
$518.39
Total Value
$124.41K
Shares Held After
49,773
% of Holdings
0.5%
Mar 23, 2026
Sale
Shares
200
Price
$530.00
Total Value
$106.00K
Shares Held After
4,245
% of Holdings
4.5%

Vir Biotechnology, Inc. (VIR)

Sabatini Brent — SVP, Chief Accounting Officer
Mar 23, 2026
Sale
Shares
7,711
Price
$9.12
Total Value
$70.32K
Shares Held After
61,902
% of Holdings
11.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
160
Price
$536.27
Total Value
$85.80K
Shares Held After
18,876
% of Holdings
0.8%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
440
Price
$535.34
Total Value
$235.55K
Shares Held After
19,036
% of Holdings
2.3%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
506
Price
$534.60
Total Value
$270.51K
Shares Held After
19,476
% of Holdings
2.5%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
642
Price
$533.60
Total Value
$342.57K
Shares Held After
19,982
% of Holdings
3.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
288
Price
$532.59
Total Value
$153.39K
Shares Held After
20,624
% of Holdings
1.4%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
587
Price
$531.49
Total Value
$311.98K
Shares Held After
20,912
% of Holdings
2.7%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
577
Price
$530.64
Total Value
$306.18K
Shares Held After
21,499
% of Holdings
2.6%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
2,620
Price
$529.04
Total Value
$1.39M
Shares Held After
22,076
% of Holdings
10.6%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
80
Price
$527.49
Total Value
$42.20K
Shares Held After
24,696
% of Holdings
0.3%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
520
Price
$526.57
Total Value
$273.82K
Shares Held After
24,776
% of Holdings
2.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
320
Price
$525.37
Total Value
$168.12K
Shares Held After
25,296
% of Holdings
1.2%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
440
Price
$524.20
Total Value
$230.65K
Shares Held After
25,616
% of Holdings
1.7%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
200
Price
$522.36
Total Value
$104.47K
Shares Held After
26,056
% of Holdings
0.8%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
905
Price
$521.47
Total Value
$471.93K
Shares Held After
26,256
% of Holdings
3.3%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
875
Price
$520.62
Total Value
$455.54K
Shares Held After
27,161
% of Holdings
3.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
640
Price
$519.30
Total Value
$332.35K
Shares Held After
28,036
% of Holdings
2.2%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 23, 2026
Sale
Shares
200
Price
$518.28
Total Value
$103.66K
Shares Held After
28,676
% of Holdings
0.7%
Shares
200
Price
$63.01
Total Value
$12.60K
Shares Held After
1,223,579
% of Holdings
0.0%
Shares
1,513
Price
$62.62
Total Value
$94.74K
Shares Held After
1,223,779
% of Holdings
0.1%
Shares
787
Price
$61.70
Total Value
$48.56K
Shares Held After
1,225,292
% of Holdings
0.1%
Shares
31,425
Price
$60.23
Total Value
$1.89M
Shares Held After
1,226,079
% of Holdings
2.5%
Mar 23, 2026
Purchase
Shares
1,000
Price
$0.75
Total Value
$749.90
Shares Held After
10,202,229
% of Holdings
0.0%
Mar 23, 2026
Purchase
Shares
23,033
Price
$0.68
Total Value
$15.66K
Shares Held After
10,201,229
% of Holdings
0.2%

Immunome Inc. (IMNM)

WAGENHEIM PHILIP — Director
Mar 23, 2026
Sale
Shares
28,200
Price
$20.65
Total Value
$582.33K
Shares Held After
341,147
% of Holdings
7.6%
Mar 23, 2026
Sale
Shares
19,060
Price
$13.83
Total Value
$263.60K
Shares Held After
481,906
% of Holdings
3.8%
Mar 23, 2026
Sale
Shares
118,000
Price
$17.48
Total Value
$2.06M
Shares Held After
2,354,641
% of Holdings
4.8%

Hims & Hers Health, Inc. (HIMS)

Okupe Oluyemi — Chief Financial Officer
Mar 20, 2026
Sale
Shares
9,217
Price
$23.77
Total Value
$219.07K
Shares Held After
318,789
% of Holdings
2.8%
Mar 20, 2026
Sale
Shares
11,628
Price
$0.85
Total Value
$9.86K
Shares Held After
3,871,996
% of Holdings
0.3%

4D Molecular Therapeutics, Inc. (FDMT)

Gupta Ashoo — VP, Finance and Controller
Mar 20, 2026
Sale
Shares
80
Price
$8.61
Total Value
$688.80
Shares Held After
47,055
% of Holdings
0.2%

4D Molecular Therapeutics, Inc. (FDMT)

Gupta Ashoo — VP, Finance and Controller
Mar 20, 2026
Sale
Shares
310
Price
$8.61
Total Value
$2.67K
Shares Held After
46,914
% of Holdings
0.7%

Quantum-Si Inc (QSI)

Keyes Jeffry R. — Chief Financial Officer
Mar 20, 2026
Sale
Shares
4,233
Price
$0.85
Total Value
$3.59K
Shares Held After
1,811,767
% of Holdings
0.2%

Quantum-Si Inc (QSI)

LaPointe Christian — GC & Corp. Secretary
Mar 20, 2026
Sale
Shares
5,849
Price
$0.85
Total Value
$4.96K
Shares Held After
1,204,127
% of Holdings
0.5%

Quantum-Si Inc (QSI)

Vieceli John S. — Chief Product Officer
Mar 20, 2026
Sale
Shares
10,758
Price
$0.85
Total Value
$9.13K
Shares Held After
1,181,896
% of Holdings
0.9%

CORCEPT THERAPEUTICS INC (CORT)

Guyer William — Chief Development Officer
Mar 20, 2026
Sale
Shares
11,767
Price
$36.01
Total Value
$423.73K
Shares Held After
2,231
% of Holdings
84.1%

Tarsus Pharmaceuticals, Inc. (TARS)

Neervannan Seshadri — Chief Operating Officer
Mar 20, 2026
Sale
Shares
2,989
Price
$66.75
Total Value
$199.52K
Shares Held After
82,791
% of Holdings
3.5%
Mar 20, 2026
Sale
Shares
275,728
Price
$29.68
Total Value
$8.18M
Shares Held After
345,123
% of Holdings
44.4%
Mar 20, 2026
Sale
Shares
827,636
Price
$29.68
Total Value
$24.57M
Shares Held After
1,035,928
% of Holdings
44.4%
Mar 20, 2026
Sale
Shares
3,570,677
Price
$29.68
Total Value
$105.99M
Shares Held After
4,469,316
% of Holdings
44.4%
Mar 20, 2026
Sale
Shares
187,855
Price
$29.68
Total Value
$5.58M
Shares Held After
254,472
% of Holdings
42.5%

Guardian Pharmacy Services, Inc. (GRDN)

Pharmacy Investors, LLC — Member of 10% owner group
Mar 20, 2026
Sale
Shares
827,636
Price
$29.68
Total Value
$24.57M
Shares Held After
1,035,928
% of Holdings
44.4%
Version: v26.3.29